3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
US6506763B2 · kind B2 · utility
50Cited by
13References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2001 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Jul 30, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/34
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to novel 3-(substituted)-2-indolinones compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related disorders such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.